Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers: BioSample: SAMN36729136; Sample name: BWH_1164_E_col; SRA: SRS18433670

Organism: Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_1164_E_col
collected by	Brigham and Women's Hospital
collection date	2023
geographic location	USA:Boston
host	Homo sapiens
host disease	Abdominal abscess
isolation source	Abdominal abscess
latitude and longitude	42.3362 N 71.1067 W
host age	35

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-07-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	susceptible	<=	2/1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	resistant	>=	32	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	susceptible	<=	4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
daptomycin	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
doxycycline	intermediate	==	8.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	resistant	>=	8	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
streptomycin	susceptible	<=	1000	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	susceptible	==	1.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI

Accession:: SAMN36729136
ID:: 36729136

BioProject SRA Nucleotide

BioSample

National Center for Biotechnology Information

Result Filters

Send to:

Links from Nucleotide

Pathogen: clinical or host-associated sample from Escherichia coli

Supplemental Content

Related information

Recent activity